Professor of Medicine (Retired)
Harvard Medical School
Chief Medical Officer
Boston Scientific Corporation
Boston, Massachusetts
Session Moderator
SESSION 17: MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH - PART 1
Session Moderator
SESSION 18: MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH – PART 2
Presenter
SESSION 17: MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH - PART 1
Presentation Moderator
SESSION 17: MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH - PART 1
Presentation Moderator
SESSION 18: MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH – PART 2
Session Moderator
SESSION 31: ADVANCES IN MEDICAL DIAGNOSIS AND TREATMENTS IN VASCULAR PATIENTS; NEW ANTI-ATHEROGENIC DRUGS AND RIVAROXABAN
SESSION 17: MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH - PART 1
Session Moderator
SESSION 18: MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH – PART 2
Presenter
SESSION 17: MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH - PART 1
Welcome And Introduction
7:05 AM - 7:15 AM
Presentation Moderator
SESSION 17: MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH - PART 1
Presentation Moderator
SESSION 18: MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH – PART 2
Session Moderator
SESSION 31: ADVANCES IN MEDICAL DIAGNOSIS AND TREATMENTS IN VASCULAR PATIENTS; NEW ANTI-ATHEROGENIC DRUGS AND RIVAROXABAN